Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026)
Arbutus Biopharma (ABUS) posted Exchange Rate Effect of -$10000.0 for Q1 2026, down 1100.0% sequentially from $1000.0 in Q4 2025, and down 350.0% YoY from $4000.0 in Q1 2025.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Arbutus Biopharma has reported Exchange Rate Effect for 14 years, with the latest figure at -$10000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 350.0% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $14000.0 (up 128.57% YoY) and the FY2025 annual result came in at $14000.0, up 128.57% from the prior year.
- Exchange Rate Effect eased to -$10000.0 in Q1 2026 per ABUS's latest filing, from $1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $21000.0 in Q2 2025 and troughed at -$33000.0 in Q4 2024.
- A 5-year average of -$2800.0 and a median of -$1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect surged 450.0% in 2023, then sank 700.0% in 2024.
- Over 5 years, Exchange Rate Effect stood at -$4000.0 in 2022, then soared by 450.0% to $14000.0 in 2023, then sank by 335.71% to -$33000.0 in 2024, then jumped by 103.03% to $1000.0 in 2025, then plunged by 1100.0% to -$10000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$10000.0, $1000.0, and -$12000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Arbutus Biopharma | 1.02 Bn | 927.31 Mn | - | -4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | -18,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Mar 31, 2021 | -44,000.00 |
| Dec 31, 2020 | 112,000.00 |